Iconovo (Sweden) Today
| ICO Stock | SEK 1.09 0.05 4.81% |
PerformanceWeakest
| Odds Of DistressHigh
|
Iconovo is selling for under 1.09 as of the 16th of February 2026; that is 4.81% increase since the beginning of the trading day. The stock's last reported lowest price was 1.04. Iconovo has more than 64 % chance of experiencing financial distress in the next few years of operation. It also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 18th of November 2025 and ending today, the 16th of February 2026. Click here to learn more.
Iconovo AB develops and licenses inhalation devices in Sweden. Iconovo AB was founded in 2013 and is based in Lund, Sweden. Iconovo AB operates under Medical Devices classification in Sweden and is traded on Stockholm Stock Exchange. It employs 27 people. The company has 8.85 M outstanding shares. More on Iconovo
Moving together with Iconovo Stock
Moving against Iconovo Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Iconovo Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Iconovo's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Iconovo or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Medical Devices, Healthcare (View all Sectors) |
Iconovo (ICO) is traded on Stockholm Exchange in Sweden and employs 31 people. The company currently falls under 'Small-Cap' category with a current market capitalization of 389.29 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Iconovo's market, we take the total number of its shares issued and multiply it by Iconovo's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Iconovo operates under Healthcare sector and is part of Medical Devices industry. The entity has 8.85 M outstanding shares.
Iconovo has accumulated about 94.94 M in cash with (11.01 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.84, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Iconovo Probability Of Bankruptcy
Ownership AllocationThe market capitalization of Iconovo is kr389.29 Million. Iconovo secures significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.
Check Iconovo Ownership Details
Iconovo Risk Profiles
Although Iconovo's alpha and beta are two of the key measurements used to evaluate Iconovo's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.33 | |||
| Standard Deviation | 3.11 | |||
| Variance | 9.68 | |||
| Risk Adjusted Performance | (0.17) |
Iconovo Stock Against Markets
Iconovo Stock Analysis Notes
About 48.0% of the company shares are held by company insiders. The book value of Iconovo was currently reported as 11.96. The company recorded a loss per share of 3.31. Iconovo had not issued any dividends in recent years. Iconovo AB develops and licenses inhalation devices in Sweden. Iconovo AB was founded in 2013 and is based in Lund, Sweden. Iconovo AB operates under Medical Devices classification in Sweden and is traded on Stockholm Stock Exchange. It employs 27 people. To learn more about Iconovo call the company at 46 4 62 75 67 77 or check out https://www.iconovo.se.Iconovo Investment Alerts
| Iconovo generated a negative expected return over the last 90 days | |
| Iconovo has some characteristics of a very speculative penny stock | |
| Iconovo has high historical volatility and very poor performance | |
| Iconovo has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 15.41 M. Net Loss for the year was (26.16 M) with profit before overhead, payroll, taxes, and interest of 21.31 M. | |
| Iconovo has accumulated about 94.94 M in cash with (11.01 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.84, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 48.0% of the company shares are held by company insiders |
Iconovo Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 389.29 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Iconovo's market, we take the total number of its shares issued and multiply it by Iconovo's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Iconovo Profitablity
Iconovo's profitability indicators refer to fundamental financial ratios that showcase Iconovo's ability to generate income relative to its revenue or operating costs. If, let's say, Iconovo is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Iconovo's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Iconovo's profitability requires more research than a typical breakdown of Iconovo's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (1.18) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (1.2) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $1.2. Technical Drivers
As of the 16th of February 2026, Iconovo retains the Market Risk Adjusted Performance of (0.84), standard deviation of 3.11, and Risk Adjusted Performance of (0.17). Iconovo technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.Iconovo Price Movement Analysis
Transformation |
The output start index for this execution was zero with a total number of output elements of sixty-one. Iconovo Tanh Of Price Series is a hyperbolic price transformation function.
Iconovo Outstanding Bonds
Iconovo issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Iconovo uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Iconovo bonds can be classified according to their maturity, which is the date when Iconovo has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Iconovo Predictive Daily Indicators
Iconovo intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Iconovo stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Iconovo Forecast Models
Iconovo's time-series forecasting models are one of many Iconovo's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Iconovo's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.Be your own money manager
Our tools can tell you how much better you can do entering a position in Iconovo without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Equity Valuation Now
Equity ValuationCheck real value of public entities based on technical and fundamental data |
| All Next | Launch Module |
Iconovo Corporate Management
Elected by the shareholders, the Iconovo's board of directors comprises two types of representatives: Iconovo inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Iconovo. The board's role is to monitor Iconovo's management team and ensure that shareholders' interests are well served. Iconovo's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Iconovo's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Carl Forslund | Head Design | Profile | |
| Orest Lastow | CoFounder CTO | Profile | |
| Mikael Arinder | VP Operations | Profile | |
| Johan Waborg | Chief Officer | Profile | |
| Peter Akerlund | Chief Officer | Profile | |
| Eva Norell | Communications Mang | Profile |
Additional Tools for Iconovo Stock Analysis
When running Iconovo's price analysis, check to measure Iconovo's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Iconovo is operating at the current time. Most of Iconovo's value examination focuses on studying past and present price action to predict the probability of Iconovo's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Iconovo's price. Additionally, you may evaluate how the addition of Iconovo to your portfolios can decrease your overall portfolio volatility.